From October 1, 2023 to December 31, 2023, the company has repurchased 6,287,800 shares, representing 1.14% for CNY 65.64 million. With this, the company has completed the repurchase of 8,118,100 shares, representing 1.48% for CNY 86.69 million under the buyback announced on September 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.79 CNY | -1.64% | +1.12% | -8.64% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.64% | 804M | |
+20.91% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+11.99% | 13.64B | |
+39.15% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 300401 Stock
- News Zhejiang Garden Biopharmaceutical Co.,Ltd.
- Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.